Home
  >  
Section 1
  >  
Chapter 888

Fate of Toxoplasma in cats after oral administration

Hagiwara, T.; Katsube, Y.; Imaizumi, K.

Nihon Juigaku Zasshi. Japanese Journal of Veterinary Science 43(3): 337-343

1981

ISSN/ISBN: 0021-5295
PMID: 7321360
DOI: 10.1292/jvms1939.43.337
Accession: 000887305
Download citation:  
Text
  |  
BibTeX
  |  
RIS
Mouse brains infected with Toxoplasma (strain NF-21) were given orally to 21 cats and the cats were killed at intervals up to 28 days later. The cats showed neither clinical signs nor gross lesions. On day one Toxoplasma was isolated from the small intestine and the small intestinal lymph node. Thereafter the organism spread and by days 10 to 14 almost all extraintestinal tissues became infected. Oocysts were detected in faeces from days 4 to 14.

PDF emailed within 0-6 h: $19.90




Related References

Hagiwara, T.; Katsube, Y.; Imaizumi, K. 1981: Fate of toxoplasma strain nf 21 in cats after oral administration Japanese Journal of Veterinary Science 43(3): 337-344
Lappin, M.R.; VanLare, K.A.; Seewald, W.; Roycroft, L.M.; Scorza, A.V.; King, S.; Roberts, E.S. 2015: Effect of oral administration of cyclosporine on Toxoplasma gondii infection status of cats American Journal of Veterinary Research 76(4): 351-357
Kühn, D.; Weiland, G. 1969: Experimental Toxoplasma infections in cats. I. Repeated transmission of Toxoplasma gondii through feces of cats infected by nematodes Berliner und Munchener Tierarztliche Wochenschrift 82(20): 401-404
Kadar, D.; Lovrics, A.J.; Endrenyi, L. 1978: The fate of [7-3H]isoproterenol in cats after intravenous administration Drug Metabolism and Disposition: the Biological Fate of Chemicals 6(4): 476-480
Nery Guimaraes, F.; Lage, H.A. 1973: The irregular and inconstant production of oocysts by the administration of toxoplasma gondii cysts in cats Memorias do Instituto Oswaldo Cruz 70(1-2): 157-169
Slingsby, L.S.; Taylor, P.M.; Monroe, T. 2009: Thermal antinociception after dexmedetomidine administration in cats: a comparison between intramuscular and oral transmucosal administration Journal of Feline Medicine and Surgery 11(10): 829-834
Pampiglione, S.; Yasslu, SMA.; Berengo, A. de Lalla, F. 1975: Contribution to the study of the experimental oral infection of cats and other animals with Toxoplasma gondii Journal Egypt Soc Parasit, 4-5: 65-79
Shindo, H.; Komai, T.; Nakajima, E. 1972: Metabolic fate and mechanism of action of chloroethylthiamine. II. Movement and fate of chloroethylthiamine along intestinal lumen after oral administration to chick Journal of Vitaminology 18(1): 48-54
Ichikawa, M.; Haruki, S.; Esumi, Y.; Takaichi, M.; Seki, H.; Miyake, T.; Hagiya, H.; Shiina, M. 1992: Metabolic fate of Bevantolol hydrochloride : metabolic fate after repeated oral administration, and transfer into fetus and milk rats Yakuri to Chiryo 20(5): 229-241
Kuhn, D.; Warnecke, M.; Centurier, H. 1973: Studies on the possibility of the excretion of toxoplasms in the secretions and excreta of cats after oral infection with Toxoplasma cysts and oocysts Berliner und Münchener Tierärztliche Wochenschrift 86(4): 69-72
Westerhoff, J. 1984: Attempts to suppress Toxoplasma oocyst shedding using medicated feed in latently infected cats and after oral infection with oocysts Versuche zur Unterdruckung der Toxoplasma Oozystenausscheidung durch medikiertes Futter bei latent infizierten Katzen sowie nach infektion mit Oozysten: 58
Gehring, P.J.; Kramer, C.G.; Schwetz, B.A.; Rose, J.Q.; Rowe, V.K.; Zimmer, J.S. 1973: The fate of 2 4 5 t following oral administration to man Toxicology and Applied Pharmacology 25(3): 441
Sauerhoff, M.W.; Braun, W.H.; Blau, G.E.; Gehring, P.J. 1977: The fate of 2 4 d following oral administration to man Toxicology 8(1): 3-12
Ashbel, S.I.; Khil, R.G.; Sokolova, V.G.; Pertsovich, I.K. 1971: Fate of sulfamonomethoxine following per oral administration Kazanskii Meditsinskii Zhurnal 4: 40-41
Shindo, H.; Komai, T.; Nakajima, E. 1971: Metabolic fate and mechanism of action of chloroethyl thiamine part 2 movement and fate of chloroethyl thiamine along intestinal lumen after oral administration to chick Journal of Vitaminology 18(1): 48-54
Taira, K.; Yasuda, Y.; Shindo, T.; Mitani, N.; Akazawa, A. 1980: The biological fate of 4-butyl-4-(beta-carboxypropionyloxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione (suxibuzone), antiinflammatory drug. II. The biological fate of suxibuzone (SB) after daily oral administration Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 100(3): 272-279
Akinshina, G.T.; Abakarova, E.G.; Kirillova, F.; M. 1975: Toxoplasma gondii: the fate of toxoplasma in the macrophages in vitro depending on the virulence of parasites. Byulleten' eksp Biol Med 8011: 60-63
Sauerhoff, M.W.; Chenoweth, M.B.; Gordon, H.L.; Braun, W.H.; Blau, G.E.; Gehring, P.J. 1977: The fate of silvex following oral administration to humans Toxicology and Applied Pharmacology 41(1): 162-163
Gehring, P.J.; Kramer, C.G.; Schwetz, B.A.; Rose, J.Q.; Rowe, V.K. 1973: The fate of 2,4,5-trichlorophenoxyacetic acid (2,4,5-T) following oral administration to man Toxicology and Applied Pharmacology 26(3): 352-361
Sauerhoff, M.W.; Chenoweth, M.B.; Karbowski, R.,.; Braun, W.H.; Ramsey, J.C.; Gehring, P.J.; Blau, G.E. 1977: Fate of silvex following oral administration to humans Journal of Toxicology and Environmental Health 3(5-6): 941-952